Abstract:Purpose: Neuropeptide Y (NPY) is an endogenous 36‐amino acid linear peptide with tyrosine residues on both ends of the molecule. Cumulative evidence suggests that NPY and its receptors in the CNS may be a potential neuroprotective targets in various degenerative conditions. This study aimed to investigate the protective effects of NPY in the retina in an experimentally induced glaucoma animal model. Methods: Weekly intracameral microbead injections were performed to induce sustainably increased intraocular pressure (IOP) and NPY was administered intravitreally for 2 months. Wild‐type C57BL/6J mice ( n = 40) were categorized into four major groups i) control, ii) control + NPY, iii) high IOP model, & iv) high IOP + NPY. Inner retinal function was evaluated by using positive scotopic threshold response (pSTR) amplitudes. Eye and optic nerve sections were then immunostained with pNFH (phosphorylated neurofilament heavy chain), GFAP (glial fibrillary acidic protein) and Iba‐1(Ionized calcium‐binding adaptor molecule 1) antibodies to understand the protective effects of NPY treatment. Results: IOP elevation was observed in the microbead model (control, 10.5 ± 0.75; microbead, 27.35 ± 1.92 mmHg). Functional data revealed a significant decline in the pSTR amplitudes in high IOP conditions ( p < 0.0001, n = 10) compared to the control group, and a significant increase in pSTR was observed in the high IOP + NPY group ( p < 0.001, n = 10). Optic nerves stained with pNFH revealed a significant protective effect of NPY treatment against high IOP‐induced axonal damage ( p < 0.01, n = 4). Increased GFAP expression observed in high IOP condition was significantly decreased with NPY treatment both in the retina ( p < 0.001, n = 4) and optic nerves ( p < 0.01, n = 4). Similarly, microglial activation evaluated by Iba‐1 expression was also significantly decreased by NPY treatment both in the retina ( p < 0.01, n = 4) and optic nerves ( p < 0.01, n = 4). Conclusions: NPY treatment significantly reduced inner retinal functional loss and optic nerve damage against high IOP‐induced glaucomatous injury. NPY also reduced the microglial activation and reactive gliosis in experimental glaucoma. Our ongoing investigation will reveal specific NPY receptors activation and biochemical mechanism underlying these protective effects in the retina.

Effects of tetramethylpyrazine on retina of rabbits with experimental glaucoma

Protective effects of TMP on the retinal ganglions and bipolar cells of rabbits with elevated intraocular pressure

Tetramethylpyrazine (TMP), an Active Ingredient of Chinese Herb Medicine Chuanxiong, Attenuates the Degeneration of Trabecular Meshwork through SDF-1/CXCR4 Axis

Effects of tetramethylpyrazine on lipid peroxidation and appoptosis in rabbits by spinal cord ischemia/reperfusion

Anti-apoptotic and Neuroprotective Effects of Tetramethylpyrazine Following Spinal Cord Ischemia in Rabbits

Effects of tetramethylpyrazine on cell proliferation in dentate gyrus in rat brain after cerebral ischemia-reperfusion injury

Protective effects of triptolide on retinal ganglion cells in a rat model of chronic glaucoma.

Protective effect of triptolide on retinal ganglion cells in chronic ocular hypertension model

The Effect of A2AReceptor Antagonist on Microglial Activation in Experimental Glaucoma

Inconsistent Time-Dependent Effects of Tetramethylpyrazine on Primary Neurological Disorders and Psychiatric Comorbidities

Effects of tetramethylpyrazine on stereology of hepatocyte mitochondria in septic rats

Study on Retinal Ganglion Cell Apoptosis after Explosive Injury of Eyeballs in Rabbits.

Tetramethylpyrazine Nitrone Protects Retinal Ganglion Cells Against N-Methyl-D-Aspartate-Induced Excitotoxicity

Neuroprotective effects and mechanisms of action of artemisinin in retinal ganglion cells in a mouse model of traumatic optic neuropathy

Protective Effect of Erigeron Breviscapus(Vant.) Hand-Mazz on Retinal Ganglion Cells and Optic Nerve in Rabbits with Elevated Intraocular Pressure

TRPV4-induced Müller cell gliosis and TNF-α elevation-mediated retinal ganglion cell apoptosis in glaucomatous rats via JAK2/STAT3/NF-κB pathway

Protective effects of neuropeptide Y treatment on retina in a mouse model of experimental glaucoma

Drug Treatment Attenuates Retinal Ganglion Cell Death by Inhibiting Collapsin Response Mediator Protein 2 Phosphorylation in Mouse Models of Normal Tension Glaucoma

Tetrandrine Protects Mouse Retinal Ganglion Cells from Ischemic Injury.

Experimental Study on Tetramethylpyrazine Against Cerebral Vasospasm Following Subarachnoid Hemorrhage

Ultrasound-Enhanced Protective Effect of Tetramethylpyrazine Via the ROS/HIF-1A Signaling Pathway in an in Vitro Cerebral Ischemia/Reperfusion Injury Model.